Collaborators

Professor Angus Dalgleish, St. George’s University, London, UK.

SBL is currently providing scientific data to support future clinical trials for the treatment of melanoma.

Professor Hardev Pandha, University of Surrey, Guilford, UK

Professor Pandha and SBL are currently using SBL’s dendritic cells platform technology to investigate a series of cancer vaccines for the treatment of urological malignancies.

Professor Alan Rickinson, CRUK University of Birmingham, UK

Professor Rickinson and SBL are currently using SBL’s dendritic cells platform technology in a “proof of concept” study for the induction of EBV-specific T cells using specific RNA.

Dr Robert Kelsh, Bath University, UK

Dr. Chris Schmidt QIMR, Brisbane, Australia.

SBL are currently providing scientific data to support future clinical trials for the treatment of melanoma.